"Not sure if FDA approval will bring out a inked up deal in enough of a timeframe to relieve the continual pressure of fund raising in the interim."
Ice I have concerns about the funding position. I am awaiting the June 4C to see what the cash balance is and whether the company will report any plans to raise additional. By my previous calcs we will need it before the end of this (Sept) quarter. I am still mystified about the estimates in the MST report which indicate licencing revenue in excess of $50m being received in FY21. One would think that the analyst would have consulted with the company on this item.
"Not sure if FDA approval will bring out a inked up deal in...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.56 |
Change
-0.120(0.77%) |
Mkt cap ! $335.8M | |||
| Open | High | Low | Value | Volume |
| $15.70 | $15.94 | $15.03 | $210.2K | 13.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 822 | $15.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.56 | 34 | 1 |
View Market Depth
| Last trade - 12.04pm 19/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |